State Street Global All Cap Equity ex-U.S. Index Portfolio
STATE STREET INSTITUTIONAL INVESTMENT TRUST · Series S000046032 · 1 share classes
data updated 2026-08-10
Fund profile
As filed in the prospectus · 2026 Q2
The State Street Global All Cap Equity ex-U.S. Index Portfolio (the Global All Cap Equity ex-U.S. Index Portfolio ? or the Portfolio) seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of a broad-based index of world (ex-U.S.) equity markets over the long term.
The fund tracks the MSCI ACWI ex USA Investable Market Index, a free float-adjusted market capitalization index covering developed and emerging markets outside the United States across all market capitalizations. It uses a sampling strategy, holding a subset of index securities selected to replicate the index's risk and return characteristics rather than all constituents. Because the fund samples rather than holds all index securities, its returns may diverge from the index.
| Share class | Expense ratio |
|---|---|
| SSGVX | 0.04% |
Portfolio turnover 6.00% · as of 2026 Q2
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q1
| Stocks | 97.41% |
| Cash & short-term | 4.42% |
| Other | 0.06% |
| Derivatives | 0.02% |
Derivatives are shown at market value, not notional exposure.
Latest quarter
What changed since the fund's previous filing
Largest new: Roche Holding AG, Reckitt Benckiser Group PLC, SUNB, Kotak Mahindra Bank Ltd, QIAGEN NV, Yangtze Optical Fibre & Cable Joint Stock Ltd Co, ICE Futures U.S., Inc., SenseTime Group Inc
Largest exited: Roche Holding AG, Reckitt Benckiser Group PLC, Ashtead Group PLC, Kotak Mahindra Bank Ltd, CyberArk Software Ltd, Toyota Industries Corp, Hang Seng Bank Ltd, QIAGEN NV
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Feb 2026
Mar 2026 has been filed since the trailing figures were struck, so it is not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Value | Shares |
|---|---|---|---|---|
| — | State Street Global Advisors | 4.42% | $492.66M | — |
| — | Taiwan Semiconductor Manufacturing Co Ltd | 3.60% | $401.14M | 6.9M |
| — | Samsung Electronics Co Ltd | 1.41% | $156.82M | 1.3M |
| — | ASML Holding NV | 1.29% | $144.13M | 108.7K |
| — | Tencent Holdings Ltd | 1.01% | $112.94M | 1.8M |
| — | SK hynix Inc | 0.78% | $86.78M | 153.0K |
| — | AstraZeneca PLC | 0.76% | $84.16M | 432.0K |
| — | Novartis AG | 0.73% | $80.90M | 529.6K |
| — | HSBC Holdings PLC | 0.70% | $78.46M | 4.8M |
| — | Roche Holding AG | 0.70% | $77.73M | 195.7K |
Top 10 positions are 15.39% of net assets, top 25 22.82%, across 5.6K issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free